Language selection

Government of Canada / Gouvernement du Canada

Search

The use of bivalent factor H binding protein Meningococcal Serogroup B (MenB-fHBP) vaccine for the prevention of meningococcal B disease.: HP40-263/2019E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.881875&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada.
TitleThe use of bivalent factor H binding protein Meningococcal Serogroup B (MenB-fHBP) vaccine for the prevention of meningococcal B disease.
Variant title
  • At head of title : An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Utilisation du vaccin bivalent dirigé contre la protéine de liaison au facteur H (MenB-fHBP) pour la prévention de l’infection à méningocoque du sérogroupe B.
  • "Publication date: December 2019."
  • Includes bibliographical references (pages 49-52).
Publishing information
  • [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, 2019.
  • ©2019
Description1 online resource (88 pages) : colour charts
ISBN9780660332116
Catalogue number
  • HP40-263/2019E-PDF
Departmental catalogue number190444
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: